The role of pharmacists in
identifying overdose risks from OTC
codeine products was among issues
raised yesterday at the APSAD
2016 Scientific Alcohol and Drugs
Conference in Sydney.
Research presented at the event
showed the misuse of OTC codeine
in Australia cost an average $10,000
per hospital admission.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Nov 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Nov 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.